Abstract
Eating disorder is a group of physiological and psychological disorders affecting approximately 1% of the female population worldwide. Although the genetic epidemiology of eating disorder is becoming increasingly clear with accumulated studies, the underlying molecular mechanisms are still unclear. Recently, integration of various high-throughput data expanded the range of candidate genes and started to generate hypotheses for understanding potential pathogenesis in complex diseases. This article presents EDdb (Eating Disorder database), the first evidence-based gene resource for eating disorder. Fifty-nine experimentally validated genes from the literature in relation to eating disorder were collected as the core dataset. Another four datasets with 2824 candidate genes across 601 genome regions were expanded based on the core dataset using different criteria (e.g., protein-protein interactions, shared cytobands, and related complex diseases). Based on human protein-protein interaction data, we reconstructed a potential molecular sub-network related to eating disorder. Furthermore, with an integrative pathway enrichment analysis of genes in EDdb, we identified an extended adipocytokine signaling pathway in eating disorder. Three genes in EDdb (ADIPO (adiponectin), TNF (tumor necrosis factor) and NR3C1 (nuclear receptor subfamily 3, group C, member 1)) link the KEGG (Kyoto Encyclopedia of Genes and Genomes) “adipocytokine signaling pathway” with the BioCarta “visceral fat deposits and the metabolic syndrome” pathway to form a joint pathway. In total, the joint pathway contains 43 genes, among which 39 genes are related to eating disorder. As the first comprehensive gene resource for eating disorder, EDdb (http://eddb.cbi.pku.edu.cn) enables the exploration of gene-disease relationships and cross-talk mechanisms between related disorders. Through pathway statistical studies, we revealed that abnormal body weight caused by eating disorder and obesity may both be related to dysregulation of the novel joint pathway of adipocytokine signaling. In addition, this joint pathway may be the common pathway for body weight regulation in complex human diseases related to unhealthy lifestyle.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bulik C M, Hebebrand J, Keski-Rahkonen A, et al. Genetic epidemiology, endophenotypes, and eating disorder classification. Int J Eat Disord, 2007, 40: S52–60
Swanson S A, Crow S J, Le Grange D, et al. Prevalence and correlates of eating disorders in adolescents: Results from the national comorbidity survey replication adolescent supplement. Arch Gen Psychiatry, 2011, 68: 714–723
Wang K, Zhang H, Bloss C S, et al. A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa. Mol Psychiatry, 2010, 16: 949–959
Hudson J I, Hiripi E, Pope H G Jr., et al. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry, 2007, 61: 348–358
Becker K G, Barnes K C, Bright T J, et al. The genetic association database. Nat Genet, 2004, 36: 431–432
Chanoine P, Spector N D. Hyperlipidemia, eating disorders, and smoking cessation. Curr Opin Pediatr, 2008, 20: 734–739
Anzengruber D, Klump K L, Thornton L, et al. Smoking in eating disorders. Eat Behav, 2006, 7: 291–299
Morgan J F, Lacey J H. Smoking, eating disorders, and weight control. Postgrad Med J, 1999, 75: 127
Dean E, Lomi C, Bruno S, et al. Addressing the common pathway underlying hypertension and diabetes in people who are obese by maximizing health: The ultimate knowledge translation gap. Int J Hypertens, 2011, 2011: 835805
Schwartz M B, Henderson K E. Does obesity prevention cause eating disorders? J Am Acad Child Adolesc Psychiatry, 2009, 48: 784–786
Waaddegaard M, Davidsen M, Kjoller M. Obesity and prevalence of risk behaviour for eating disorders among young Danish women. Scand J Public Health, 2009, 37: 736–743
Day J, Ternouth A, Collier D A. Eating disorders and obesity: two sides of the same coin? Epidemiol Psichiatr Soc, 2009, 18: 96–100
Nishisono F M. Understanding of and therapy for eating disorders-psychiatric views. Seishin Shinkeigaku Zasshi, 2009, 111: 854–858
Lee S, Ng K L, Kwok K, et al. The changing profile of eating disorders at a tertiary psychiatric clinic in Hong Kong (1987–2007). Int J Eat Disord, 2010, 43: 307–314
Javaras K N, Pope H G, Lalonde J K, et al. Co-occurrence of binge eating disorder with psychiatric and medical disorders. J Clin Psychiatry, 2008, 69: 266–273
Blinder B J. Eating disorders in psychiatric illness. West J Med, 1991, 155: 519–520
Hinney A, Nguyen T T, Scherag A, et al. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS ONE, 2007, 2: e1361
Scuteri A, Sanna S, Chen W M, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet, 2007, 3: e115
Pinheiro A P, Bulik C M, Thornton L M, et al. Association study of 182 candidate genes in anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet, 2010, 153B: 1070–1080
Scherag S, Hebebrand J, Hinney A. Eating disorders: The current status of molecular genetic research. Eur Child Adolesc Psychiatry, 2010, 19: 211–226
Stark C, Breitkreutz B J, Chatr-Aryamontri A, et al. The BioGRID Interaction Database: 2011 update. Nucleic Acids Res, 2011, 39: D698–D704
Prasad T S, Goel R, Kandasamy K, et al. Human Protein Reference Database-2009 update. Nucleic Acids Res, 2008, 37: D767–772
Willis R C, Hogue C W. Searching, viewing, and visualizing data in the Biomolecular Interaction Network Database (BIND). Curr Protoc Bioinform, 2006, Chapter 8, Unit 8.9
Maglott D, Ostell J, Pruitt K D, et al. Entrez Gene: Gene-centered information at NCBI. Nucleic Acids Res, 2011, 39: D52–57
Hermjakob H, Fleischmann W, Apweiler R. Swissknife — ‘lazy parsing’ of SWISS-PROT entries. Bioinformatics, 1999, 15: 771–772
Croft D, O’Kelly G, Wu G, et al. Reactome: A database of reactions, pathways and biological processes. Nucleic Acids Res, 2011, 39: D691–697
Feramisco J D, Sadreyev R I, Murray M L, et al. Phenotypic and genotypic analyses of genetic skin disease through the Online Mendelian Inheritance in Man (OMIM) database. J Invest Dermatol, 2009, 129: 2628–2636
Kanehisa M, Goto S, Hattori M, et al. From genomics to chemical genomics: New developments in KEGG. Nucleic Acids Res, 2006, 34: D354–357
Nishimura D. BioCarta. Biotech Softw Internet Rep, 2001, 2: 117–120
Kong L, Cheng L, Fan L Y, et al. IQdb: An intelligence quotient score-associated gene resource for human intelligence. Database (Oxford), 2013, 2013: bat063
Zhao M, Qu H. PathLocdb: A comprehensive database for the subcellular localization of metabolic pathways and its application to multiple localization analysis. BMC Genomics, 2010, 11: S13
Zhao M, Chen X, Gao G, et al. RLEdb: A database of rate-limiting enzymes and their regulation in human, rat, mouse, yeast and E. coli. Cell Res, 2009, 19: 793–795
Zhao M, Chen Y, Qu D, et al. TSdb: A database of transporter substrates linking metabolic pathways and transporter systems on a genome scale via their shared substrates. Sci China Life Sci, 2011, 54: 60–64
Xie C, Mao X, Huang J, et al. KOBAS 2.0: A web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res, 2011, 39: W316–322
Huang da W, Sherman B T, Lempicki R A. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res, 2009, 37: 1–13
Bialecka M, Drozdzik M, Klodowska-Duda G, et al. The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson’s disease. Acta Neurol Scand, 2004, 110: 260–266
Urwin R E, Nunn K P. Epistatic interaction between the monoamine oxidase A and serotonin transporter genes in anorexia nervosa. Eur J Hum Genet, 2005, 13: 370–375
Glaab E, Baudot A, Krasnogor N, et al. Extending pathways and processes using molecular interaction networks to analyse cancer genome data. BMC Bioinformatics, 2010, 11: 597
Lorincz A M, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer, 2006, 13: 279–292
Hoda M R, Hamza A, Fischer K, et al. Obesity as a risk factor for prostate cancer: Role for adipocytokines and involvement of tyrosine kinase pathway. Aktuelle Urol, 2010, 41: 178–183
Nakajima T E, Yamada Y, Hamano T, et al. Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci, 2010, 101: 1286–1291
Smith M R, Lee H, Fallon M A, et al. Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer. Urology, 2008, 71: 318–322
Kaur T, Zhang Z F. Obesity, breast cancer and the role of adipocytokines. Asian Pac J Cancer Prev, 2005, 6: 547–552
Housa D, Housova J, Vernerova Z, et al. Adipocytokines and cancer. Physiol Res, 2006, 55: 233–244
Housova J, Anderlova K, Krizova J, et al. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab, 2005, 90: 1366–1370
Tagami T, Satoh N, Usui T, et al. Adiponectin in anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab, 2004, 89: 1833–1837
Morton G J, Cummings D E, Baskin D G, et al. Central nervous system control of food intake and body weight. Nature, 2006, 443: 289–295
Belgardt B F, Okamura T, Bruning J C. Hormone and glucose signalling in POMC and AgRP neurons. J Physiol, 2009, 587: 5305–5314
de Piano A, Tock L, Carnier J, et al. The role of nutritional profile in the orexigenic neuropeptide secretion in nonalcoholic fatty liver disease obese adolescents. Eur J Gastroenterol Hepatol, 2010, 22: 557–563
Speliotes E K, Willer C J, Berndt S I, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet, 2010, 42: 937–948
Barth S, Klein P, Horbach T, et al. Expression of neuropeptide Y, omentin and visfatin in visceral and subcutaneous adipose tissues in humans: Relation to endocrine and clinical parameters. Obes Facts, 2010, 3: 245–251
Maury E, Brichard S M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol, 2010, 314: 1–16
Galic S, Oakhill J S, Steinberg G R. Adipose tissue as an endocrine organ. Mol Cell Endocrinol, 2010, 316: 129–139
Benton C R, Holloway G P, Han X X, et al. Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1alpha) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats. Diabetologia, 2010, 53: 2008–2019
Phillips C M, Goumidi L, Bertrais S, et al. ACC2 gene polymorphisms, metabolic syndrome, and gene-nutrient interactions with dietary fat. J Lipid Res, 2010, 51: 3500–3507
Steinberg G R, McAinch A J, Chen M B, et al. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J Clin Endocrinol Metab, 2006, 91: 3592–3597
Karp P D, Ouzounis C A, Moore-Kochlacs C, et al. Expansion of the BioCyc collection of pathway/genome databases to 160 genomes. Nucleic Acids Res, 2005, 33: 6083–6089
Cellini E, Castellini G, Ricca V, et al. Glucocorticoid receptor gene polymorphisms in Italian patients with eating disorders and obesity. Psychiatr Genet, 2010, 20: 282–288
Dostalova I, Kunesova M, Duskova J, et al. Adipose tissue resistin levels in patients with anorexia nervosa. Nutrition, 2006, 22: 977–983
Krizova J, Dolinkova M, Lacinova Z, et al. Adiponectin and resistin gene polymorphisms in patients with anorexia nervosa and obesity and its influence on metabolic phenotype. Physiol Res, 2008, 57: 539–546
Zhao M, Qu H. High similarity of phylogenetic profiles of rate-limiting enzymes with inhibitory relation in human, mouse, rat, budding yeast and E. coli. BMC Genomics, 2011, 12: S10
Zhao M, Qu H. Human liver rate-limiting enzymes influence metabolic flux via branch points and inhibitors. BMC Genomics, 2009, 10: S31
Edwards Y J, Beecham G W, Scott W K, et al. Identifying consensus disease pathways in Parkinson’s disease using an integrative systems biology approach. PLoS ONE, 2011, 6: e16917
Zhao M, Sun J, Zhao Z. Synergetic regulatory networks mediated by oncogene-driven microRNAs and transcription factors in serous ovarian cancer. Mol BioSyst, 2013, 9: 3187–3198
Andrews R C, Walker B R. Glucocorticoids and insulin resistance: Old hormones, new targets. Clin Sci (Lond), 1999, 96: 513–523
Rosmond R, Chagnon Y C, Holm G, et al. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res, 2000, 8: 211–218
Meller N, Altman A, Isakov N. New perspectives on PKCtheta, a member of the novel subfamily of protein kinase C. Stem Cells, 1998, 16: 178–192
Kim J K, Fillmore J J, Sunshine M J, et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest, 2004, 114: 823–827
Author information
Authors and Affiliations
Corresponding author
Additional information
Contributed equally to this work
This article is published with open access at Springerlink.com
Electronic supplementary material
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Zhao, M., Li, X. & Qu, H. EDdb: A web resource for eating disorder and its application to identify an extended adipocytokine signaling pathway related to eating disorder. Sci. China Life Sci. 56, 1086–1096 (2013). https://doi.org/10.1007/s11427-013-4573-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-013-4573-2